DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Amedisys - 1 Jefferies - 1 Brian Tanquilut - 1 Oppenheimer - 1 Michael Wiederhorn - 1 Leroy Leo - 1 Shounak Dasgupta - 1 Shinjini - 1
Top related locs:
Bengaluru
Top related orgs:
UnitedHealth - 1 Amedisys Inc - 1 Care Health Inc - 1 LHC - 1 Federal Trade Commission - 1 FTC - 1 Care - 1 Thomson - 1

Search resuls for: "Michael Wiederhorn"


3 mentions found


☆ UnitedHealth offers over $3 bln for home health firm Amedisys
  + stars: | 2023-06-05 | by ( Leroy Leo | ) www.reuters.com   time to read: +2 min
June 5 (Reuters) - UnitedHealth Group (UNH.N) on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc (AMED.O), pitting itself against another healthcare company set to buy the home health and hospice care firm. UnitedHealth, through its Optum unit, offered to pay $100 per share in cash, just a month after Amedisys agreed to be bought by Option Care Health Inc (OPCH.O) for $97.38 per share in an all-stock deal. If Optum's offer is accepted by Amedisys, the deal will expand UnitedHealth's presence in home healthcare that it bolstered this year through a $5.4 billion deal to buy Amedisys' rival, LHC Group. Several analysts raised concerns that a UnitedHealth deal would likely face scrutiny from the Federal Trade Commission, given UnitedHealth's home health presence. Amedisys' board has not yet determined whether Optum's offer is superior to Option Health's and is currently in exploratory discussions with the UnitedHealth unit.
Persons: Amedisys, Jefferies, Brian Tanquilut, Oppenheimer, Michael Wiederhorn, Leroy Leo, Shounak Dasgupta, Shinjini Organizations: UnitedHealth, Amedisys Inc, Care Health Inc, LHC, Federal Trade Commission, FTC, Care, Thomson Locations: Bengaluru
☆ TipRanks reveals the top 10 health care sector analysts of the past decade
  + stars: | 2023-05-21 | by ( Tipranks.Com Staff | ) www.cnbc.com   time to read: +5 min
TipRanks leveraged its Experts Center tool to recognize the ones with a high success rate. We also analyzed each stock recommendation made by health care sector analysts in the past decade. TipRanks' algorithms calculated the statistical significance of each rating, average return and the analysts' overall success rate. The buy recommendation generated a return of 397.9% from May 12, 2020 to May 12, 2021. Boris Peaker - TD CowenBoris Peaker has the 10th spot on the list, with a success rate of 47%.
☆ Humana profit beats estimates as investment income exceeds expectations
  + stars: | 2023-02-01 | by ( Khushi Mandowara Leroy Leo | Khushi Mandowara | Leroy Leo | ) www.reuters.com   time to read: +2 min
Companies Humana Inc FollowFeb 1 (Reuters) - Humana Inc (HUM.N) on Wednesday beat Wall Street estimates for quarterly profit as the health insurer's investment income jumped, even as the company reported higher-than-expected medical costs. Health insurers' costs were expected to decline on lower COVID-19-related hospitalizations, though there were concerns around a surge in flu and respiratory syncytial virus cases in the last quarter of 2022. The health insurer said it expects to add at least 625,000 members to its Medicare Advantage plan this year. Excluding one-off items, the health insurer reported a profit of $1.62 per share, higher than analysts' average estimate of $1.46 per share, according to Refinitiv data. The company's $160 million investment income was higher than Wall Street estimates of $136.7 million, Oppenheimer analyst Michael Wiederhorn said.
0 next >>
Total: 3